Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment

Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment

Purpose: Oral propranolol has been recently approved for infantile hemangiomas (IHs), but potential side effects stay a challenge. We sought to make an additional assessment on oral propranolol safety for this indication. Materials and methods: Prospective study included 108 infants consecutively tr...

Full description

Bibliographic Details
Main Authors: Jelena Petrovic, Branislav Trifunovic, Goran Vukomanovic, Mirko Topalovic, Goran Trajkovic, Vojislav Parezanović
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:Journal of Dermatological Treatment
Subjects:
oral propranolol
infantile hemangiomas
holter monitoring
Online Access:http://dx.doi.org/10.1080/09546634.2016.1277177

Similar Items

Similar Items